NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc (BMRN)

$63.94 -1.75%

Add alert

46 In band Daily RSI (14) · 18 Sep 2026

Moving averages

SMA 200$58.08+10.09%

Company profile

BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.

SectorHealthcare

IndustryBiotechnology

Market cap$12.71B

P/E ratio177.51

EPS$0.37

Beta0.238

Dividend yield0.00%

52-week high$70.98

52-week low$49.26

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 41 CRSP CRISPR Therapeutics AG RSI 55 IOVA Iovance Biotherapeutics Inc RSI 76 RXRX Recursion Pharmaceuticals Inc - Class A RSI 62 MRNA Moderna Inc RSI 63 VKTX Viking Therapeutics Inc RSI 31 SRPT Sarepta Therapeutics Inc RSI 50 EDIT Editas Medicine Inc RSI 43 NVAX Novavax Inc RSI 62

Free forever

RSI alerts for BMRN

Get an email the moment Biomarin Pharmaceutical Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 10:40 AM EDT